FDA Clearance Tracker · P020004-S039
GORE EXCLUDER AAA ENDOPROSTHESIS
Last checked: Nov 20, 2026Latest source record: Mar 5, 2009 (this decision)Source: openFDAMethods & limitations
Decided
Mar 5, 2009
Approved
Time to decision
122 days
Received Nov 3, 2008. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P020004-S039
- Device name
- GORE EXCLUDER AAA ENDOPROSTHESIS
- Applicant
- W. L. Gore & Associates, Inc.
- Applicant location
- Phonix, AZ
- Received
- Nov 3, 2008
- Decided
- Mar 5, 2009
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Original approval
- P020004
Device type
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE ADDITION OF THE 31 MM GORE EXCLUDERENDOPROSTHESIS. THE 31 MM GORE EXCLUDERS ENDOPROSTHESIS INCLUDES TWO COMPONENTSTHAT WERE NOT INCLUDED IN PRIOR SUBMISSIONS: THE 31 MM TRUNK-IPSILATERAL LEG AND THE 32MM AORTIC EXTENDER. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME GOREEXCLUDERS AAA ENDOPROSTHESIS AND IS INTENDED TO EXCLUDE THE ANEURYSM FROM BLOODCIRCULATION IN PATIENTS WHO HAVE APPROPRIATE ANATOMY AS FOLLOWS:1) ADEQUATE ILIAC/FEMORAL ACCESS;2) INFRARENAL AORTIC NECK TREATMENT DIAMETER RANGE OF 19-29 MM AND A MINIMUM AORTICNECK LENGTH OF 15 MM; 3) PROXIMAL AORTIC NECK ANGULATION LESS THAN OR EQUAL TO 60 DEGREES; AND 4) ILIAC ARTERY TREATMENT DIAMETER RANGE OF 8-18.5 MM AND ILIAC DISTAL VESSEL SEAL ZONE LENGTH OF AT LEAST 10 MM.
Source documents
Other decisions for W. L. Gore & Associates, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- GORE® VIABAHN® VBX Balloon Expandable EndoprosthesisPMA supplement
P160021-S051 · Decided Oct 8, 2026 · 244 days after receipt · Panel Track
Device type: Iliac covered stent, arterial (PRL) · Cardiology
- GORE® VIABAHN® FORTEGRA Venous StentBreakthroughPMA
P250017 · Decided Dec 19, 2025 · 182 days after receipt
Device type: Stent, vena cava (QTL) · Cardiology
K250410 · Decided Jun 2, 2025 · 109 days after receipt
Device type: Catheter, Percutaneous (DQY) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.